Johnson & Johnson withdraws 300 stents from market

	Tweet

Johnson & Johnson on Thursday said it has voluntarily withdrawn 300 of its Cypher stents from the US market after determining that the coating on six of the devices did not meet specifications.

The Cypher stent is a tiny wire mesh tubular device that props open surgically cleared arteries. It is coated with a drug that prevents the arteries from reclogging with scar tissue.

"There is no safety issue,” said company spokeswoman Terry Miller. “We are committed to quality and are being overcautious.”

RELATED STORIES:
Cheap new combination pill to help fight malaria   U.S. says J&J arthritis drug promotion misleading   Heart Risks Also Seen In Naproxen, Health Agency Says   Roche says now shipping Tamiflu to all markets   Use Caution with All Pain Medications   ADHD drug use in US rose among ages 20-44: study   FDA grants Cerexa fast track designation   FDA Approves New Insomnia Drug   New rabies vaccine promising for wildlife   US FDA says generic Wellbutrin OK despite reports   COX-1 and COX-2 enzymes may be blocked by pain medications   The Bottom Line On 10mg lexapro

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]